30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
Canada Biotechnology & Medical Research

Hemostemix Inc (HEM)

Track

The most recent insider trading activity occurred on December 16, 2025, with a Director of Issuer purchasing shares. Prior to this, several Directors of Issuer engaged in planned purchases and direct share acquisitions throughout 2025, with significant buying activity noted in August and July.
Stock chart
Ticker: HEM Exchange: CVE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Smeenk, Thomas
Director of Issuer
1 purchase — total 1,700 CAD
Buy 16 Dec 2025
Value CA$2,339,774.87 | Price 361.77 | Shares 62,158
Planned buy 3 Nov 2025
Value CA$1,058,288.37 | Price 101.07 | Shares 51,917
Planned buy 3 Nov 2025
Value CA$4,085,940.91 | Price 253.00 | Shares 35,372
Planned buy 3 Nov 2025
Value CA$55,000.00 | Price 0.11 | Shares 500,000
Buy 18 Aug 2025
Value CA$19,500.00 | Price 0.08 | Shares 260,000
Buy 11 Aug 2025
Value CA$15,000.00 | Price 0.08 | Shares 200,000
Buy 8 Aug 2025
Value CA$30,000.00 | Price 0.08 | Shares 400,000
Buy 5 Aug 2025
Value CA$23,000.00 | Price 0.12 | Shares 200,000
Buy 23 Jul 2025
Value CA$1,500,000.00 | Price 0.10 | Shares 15,000,000
Planned buy 23 Jul 2025
Value CA$10,000.00 | Price 0.10 | Shares 100,000
Planned buy 23 Jul 2025
Value CA$10,000.00 | Price 0.10 | Shares 100,000
Buy 25 Mar 2025
Value CA$5,250.00 | Price 0.11 | Shares 50,000
Buy 21 Mar 2025
Value CA$5,500.00 | Price 0.11 | Shares 50,000
Buy 6 Mar 2025
Value CA$30,000.00 | Price 0.15 | Shares 200,000
Buy 6 Mar 2025
Value CA$18,522.50 | Price 0.16 | Shares 119,500
Sale 28 Feb 2025
Value CA$8,250.00 | Price 0.17 | Shares 50,000
Sale 27 Feb 2025
Value CA$18,607.34 | Price 0.17 | Shares 110,758
Sale 27 Feb 2025
Value CA$15,575.00 | Price 0.18 | Shares 89,000
Sale 26 Feb 2025
Value CA$16,881.20 | Price 0.18 | Shares 96,464
Buy 26 Feb 2025
Value CA$35,000.00 | Price 0.18 | Shares 200,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-16 2025-12-16 B Purchase
1.5
Smeenk, Thomas

Director of Issuer

Non-Executive Director
62,158 +26.2%
361.77
CA$2,339,775 		62,158 +26.2% 361.77 CA$2,339,775
2025-11-04 2025-11-03 PP Planned purchase
Swanberg, Loran

Director of Issuer

Non-Executive Director
51,917 -39.7%
101.07
CA$1,058,288 		51,917 -39.7% 101.07 CA$1,058,288
2025-11-04 2025-11-03 PP Planned purchase
Swanberg, Loran

Director of Issuer

Non-Executive Director
35,372 +27.9%
253.00
CA$4,085,941 		35,372 +27.9% 253.00 CA$4,085,941
2025-11-04 2025-11-03 PP Planned purchase
Swanberg, Loran

Director of Issuer

Non-Executive Director
500,000 +57.8%
0.11
CA$55,000 		500,000 +57.8% 0.11 CA$55,000
2025-08-19 2025-08-18 B Purchase
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
260,000 +1.2%
0.08
CA$19,500 		260,000 +1.2% 0.08 CA$19,500
2025-08-13 2025-08-11 B Purchase
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
200,000 +0.9%
0.08
CA$15,000 		200,000 +0.9% 0.08 CA$15,000
2025-08-13 2025-08-08 B Purchase
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
400,000 +1.9%
0.08
CA$30,000 		400,000 +1.9% 0.08 CA$30,000
2025-08-06 2025-08-05 B Purchase
1.5
Smeenk, Thomas

Director of Issuer

Non-Executive Director
200,000 +5.1%
0.12
CA$23,000 		200,000 +5.1% 0.12 CA$23,000
2025-07-25 2025-07-23 B Purchase
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
15,000,000 +254.2%
0.10
CA$1,500,000 		15,000,000 +254.2% 0.10 CA$1,500,000
2025-07-23 2025-07-23 PP Planned purchase
Swanberg, Loran

Director of Issuer

Non-Executive Director
100,000 +13.1%
0.10
CA$10,000 		100,000 +13.1% 0.10 CA$10,000
2025-07-23 2025-07-23 PP Planned purchase
Swanberg, Loran

Director of Issuer

Non-Executive Director
100,000
0.10
CA$10,000 		100,000 0.10 CA$10,000
2025-03-25 2025-03-25 B Purchase
1.5
Smeenk, Thomas

Director of Issuer

Non-Executive Director
50,000 +1.3%
0.11
CA$5,250 		50,000 +1.3% 0.11 CA$5,250
2025-03-25 2025-03-21 B Purchase
1.5
Smeenk, Thomas

Director of Issuer

Non-Executive Director
50,000 +1.3%
0.11
CA$5,500 		50,000 +1.3% 0.11 CA$5,500
2025-03-10 2025-03-06 B Purchase
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
200,000 +3.5%
0.15
CA$30,000 		200,000 +3.5% 0.15 CA$30,000
2025-03-10 2025-03-06 B Purchase
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
119,500 +2.1%
0.16
CA$18,522 		119,500 +2.1% 0.16 CA$18,522
2025-02-28 2025-02-28 S Sale
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
50,000 -0.5%
0.17
CA$8,250 		50,000 -0.5% 0.17 CA$8,250
2025-02-28 2025-02-27 S Sale
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
110,758 -1.2%
0.17
CA$18,607 		110,758 -1.2% 0.17 CA$18,607
2025-02-28 2025-02-27 S Sale
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
89,000 -0.9%
0.18
CA$15,575 		89,000 -0.9% 0.18 CA$15,575
2025-02-28 2025-02-26 S Sale
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
96,464
0.18
CA$16,881 		96,464 0.18 CA$16,881
2025-02-28 2025-02-26 B Purchase
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
200,000
0.18
CA$35,000 		200,000 0.18 CA$35,000
Explore more

More insider trading research around Hemostemix Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America